AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

Roivant Sciences Ltd. Director's Dealing 2019

Dec 20, 2019

30587_dirs_2019-12-20_dfae39a8-030d-42b4-9819-960978321d1f.zip

Director's Dealing

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Immunovant, Inc. (IMVT)
CIK: 0001764013
Period of Report: 2019-12-18

Reporting Person: Roivant Sciences Ltd. (10% Owner)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock, $0.0001 par value per share	485000	Direct